In the drug utilization review, medicine and health history including all phases of dispensing for a patient is exactly listed.

[1] Also, this review is designed to attempt to attain proper decision making therapeutically and gain a positive outcome for the patient.

[5] Then, especially in the community medicine setting, Drug utilization review plays a key role for pharmacist.

This insurance decreased the cost of medication dispensing for the economic interest and create computer-based data of patient therapy information.

Drug utilization review acted as a background paper written by the United States Department of Health, Education, and Welfare task force.

[7] In community pharmacy Settings, Federal Law (OBRA-90) requires drug utilization review for patients receiving medication through Medicaid.

Recognizing that Medicaid recipients faced similar risks in the 1980s, Congress provided for the ambulatory drug utilization review under the Omnibus Budget Reconciliation Act of 1990.

[9] They are as follows: (1) reducing hospitalizations due to adverse drug events, (2) preventing and detecting fraud and abuse, and (3) supporting evidence-based prescribing through communication with others through academic details (i.e., face-to-face educational outreach by authoritative professionals in the non-profit sector).

Also, hospital and practitioners are not certain the document provided by patients is complete, and then this leads to some repeating test and medication.

If a problem occurs, practitioners are possible to prevent much worse results by ceasing the therapy during the next phase review.

[9] Also, drug utilization review technology show the possibility to the elevated pharmacy therapy over the history recording of medication.

It also helps improving the medication and drug dosage and provides feedback to hospital and practitioners for their therapy and their performance.

[3] In addition, this Drug utilization review information may also encourage practitioners to modify and alter their normal habits in prescribing and then improve care.

[3] However, the real value of such a system seems to lie in a retrospective review of practice patterns in different patients and at different times, combined with targeted educational outreach programs.

[7] In addition, there exist some major drug utilization review program problems including questions and validity in standards and highly unacceptable alert rates.

[7] The development and research of the drug utilization review program are expected and need more creative methods.

[7] Furthermore, according to a research, some hospitals did not regard prospective and concurrent drug utilization review enablers such as CDSSs, PDCS, ICPS, PIS[clarification needed] detection capabilities as standard procedures or services, as did retrospective drug utilization review.